Join Us for a Special Webcast The Genome Editing Revolution: Translating Genome Editing Technologies into Human Therapies
Free Live Webcast Thursday, November 10, 2016
3:15 – 4:45 PM EST
Panelists: J. Keith Joung (Moderator) | Alexandra Glucksmann | Fyodor Urnov | Rachel Haurwitz | James M. Wilson
Recent advances in genome editing nucleases have led to their broader application in biomedical research and dramatically accelerated efforts to develop therapeutics based on this technology. In this dynamic, interactive panel event, experts in genome editing and gene therapy from academia and industry will discuss the following topics and others relevant to clinical translation of the technology:
What are the most important recent basic science and technological advances and biggest impacts in the field of genome editing that will substantially advance the prospects of gene-based therapy?
How can the experiences of the gene therapy field inform the development of genome editing therapeutics?
What are the risks and biggest obstacles that must be minimized and overcome to successfully translate genome editing into human therapeutics?
Which diseases are the most promising candidates to benefit from genome editing therapies?
What impact, if any, has the CRISPR IP dispute had on developing gene-based therapeutics?
After a 30-minute panel discussion, the panelists will take questions from the audience. Registered attendees may submit questions in real time during the event or when registering.
Keystone Symposia on Molecular and Cellular Biology is a 501(c)(3) nonprofit organization headquartered in Colorado, USA that is directed and supported by the scientific community. 160 US Highway 6, Suite 200 | PO Box 1630 | Silverthorne, CO 80498 | USA 1-970-262-1230 | 1-800-253-0685 (in US & Canada)